Oxygen microenvironment affects the uptake of nanoparticles in head and neck tumor cells
Authors:
- 26 February 2013
- conference paper
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 8584, 85840F-112
Abstract
Survival of head and neck cancer patients has not improved in several decades despite advances in diagnostic and therapeutic techniques. Tumor hypoxia in head and neck cancers is a critical factor that leads to poor prognosis, resistance to radiation and chemotherapies, and increased metastatic potential. Magnetic nanoparticle hyperthermia (mNPHT) is a promising therapy for hypoxic tumors because nanoparticles (NP) can be directly injected into, or targeted to, hypoxic tumor cells and exposed to alternating magnetic fields (AMF) to induce hyperthermia. Magnetic NPHT can improve therapeutic effectiveness by two modes of action: 1) direct killing of hypoxic tumor cells; and 2) increase in tumor oxygenation, which has the potential to make the tumor more susceptible to adjuvant therapies such as radiation and chemotherapy. Prior studies in breast cancer cells demonstrated that a hypoxic microenvironment diminished NP uptake in vitro; however, mNPHT with intratumoral NP injection in hypoxic tumors increased tumor oxygenation and delayed tumor growth. In this study, head and neck squamous cell carcinoma (HNSCC) cell lines were incubated in normoxic, hypoxic, and hyperoxic conditions with iron oxide NP for 4-72 hours. After incubation, the cells were analyzed for iron uptake by mass spectrometry, Prussian blue staining, and electron microscopy. In contrast to breast cancer cells, uptake of NPs was increased in hypoxic microenvironments as compared to normoxic conditions in HNSCC cells. In future studies, we will confirm the effect of the oxygen microenvironment on NP uptake and efficacy of mNPHT both in vitro and in vivo.Keywords
This publication has 11 references indexed in Scilit:
- Ionizing radiation increases systemic nanoparticle tumor accumulationNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Repeated tumor pO2 measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapyRadiotherapy and Oncology, 2009
- Targeted magnetic iron oxide nanoparticles for tumor imaging and therapyInternational Journal of Nanomedicine, 2008
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and PrognosisThe Oncologist, 2008
- Hyperthermia: a Potent Enhancer of RadiotherapyClinical Oncology, 2007
- Dynamics of Tumor Hypoxia Measured with Bioreductive Hypoxic Cell MarkersRadiation Research, 2007
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Clinical applications of EPR: overview and perspectivesNMR in Biomedicine, 2004
- Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanomaThe Lancet, 1995
- Hyperthermia: An overview of current progress and problemsCurrent Problems in Cancer, 1983